【2023/4/25】Phase I Clinical Trials for CAL056 Cancer Drug Completed in Taiwan and the U.S., Confirming Its Safety READ MORE →
【2021/5/19】Calgent Received MOEA “Biotech New Drug Company” Designation for CAL056’s R&D and Manufacturing READ MORE →
